In contrast, tumor FOXP3 has been identified as a biomarker associated with malignant prognosis in pancreatic cancer, non-small cell lung cancer (NSCLC), thyroid cancer, and melanoma (34). Here, FOXP3 is linked to non-small cell lung carcinoma.